Oracle and Wipro Collaborate to Enhance Pharmacovigilance Services Using Cloud Technology

Partnership Overview

In a significant move for the healthcare industry, Oracle Life Sciences has joined forces with Wipro Limited, a prominent player in AI-driven technology services. This partnership aims to enhance Wipro's pharmacovigilance (PV) services by incorporating Oracle Life Sciences' Argus business process services (BPS). The collaboration is designed to help life sciences organizations streamline drug safety operations and ensure regulatory compliance on a global scale.

The Need for Modernized Safety Operations

As life sciences organizations face mounting pressure to upgrade their safety operations while ensuring compliance and efficiency, the integration of Oracle's Argus into Wipro's offerings comes as a timely solution. Jasjit Singh Kang, Managing Partner and Global Head of Business Process Services at Wipro Limited, emphasized the urgency of this integration: "Life sciences organizations are under increasing pressure to modernize safety operations while maintaining compliance and speed." By leveraging Oracle's capabilities, Wipro aims to provide scalable, ready-to-deploy safety services that address these critical challenges.

What Is Oracle Argus Business Process Services?

Oracle Argus BPS is a leading solution in the pharmacovigilance landscape, designed to facilitate the management of drug safety data and automate associated workflows. This solution not only aids in regulatory reporting but also enhances visibility across safety operations. With the introduction of a cloud-based model, Argus BPS allows Wipro to deliver tailored pharmacovigilance services without the complexities involved in maintaining traditional on-premises safety systems.

Flexible Pharmacovigilance Services

Wipro's pharmacovigilance services encompass a wide array of processes, including case processing, regulatory submissions, and post-marketing surveillance. The partnership aims to enable Wipro to offer enhanced case management capabilities as part of their PV services. Notably, Wipro will adopt a market-ready model, ensuring that preconfigured Oracle Argus BPS environments are available and deployment-ready even before customer onboarding begins. This streamlined approach will significantly shorten implementation timelines and facilitate quicker delivery of PV operations once deployment starts.

Enhancing Collaboration for Better Outcomes

Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, reflected on the partnership, stating, "Our collaboration with Wipro reflects the growing demand for comprehensive, cloud-based pharmacovigilance solutions that help life sciences organizations modernize safety operations and accelerate drug development." By combining Oracle's proven safety platform with Wipro's deep domain expertise, the collaboration seeks to advance life sciences innovation and support a more agile approach to pharmacovigilance.

Conclusion

The partnership between Oracle Life Sciences and Wipro Limited marks a pivotal moment for drug safety operations worldwide. Organizations are now equipped with innovative tools and frameworks designed to expedite the pharmacovigilance process while ensuring compliance. This collaboration is not just an upgrade but a transformation that promises to empower the life sciences industry, ultimately improving patient outcomes significantly.

For more insights into how Oracle's unified life sciences platform is enabling organizations to streamline drug safety operations across the entire drug lifecycle, visit Oracle's Life Sciences Portal.